logo
  

Core Laboratories NV (CLB) Is Sinking After Q4 Report

Core Laboratories NV (CLB) reported fourth quarter EPS of $1.51 after the bell Wednesday, compared to $1.42 in the prior year period. Analysts expected EPS of $1.54. The stock is now down 14.82 on 55K shares.

Core Laboratories traded to the downside throughout Wednesday's session and closed lower by 6.64 at $99.84 on the highest volume in 6 months. The stock closed testing the lower end of a 2-week trading range at the lows of the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Biotech Stocks by Subscribing to RTT Biotech Investor.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT